[ad_1]
This “Blood Preparation-Global Market Trajectory and Analysis” Report has been added to ResearchAndMarkets.com provide.
In the COVID-19 crisis, the global blood preparation market is estimated to be USD 39.3 billion in 2020 and is expected to reach a revised scale of USD 56.6 billion by 2027, with a compound annual growth rate of 5.3% during the analysis period in 2020. 2027 .
Whole blood is one of the areas analyzed in the report. It is expected that by the end of the analysis period, its compound annual growth rate will reach 5.1%, reaching 25.3 billion US dollars. After an early analysis of the commercial impact of the epidemic and the economic crisis it caused, the growth in the blood component sector was adjusted to a compound annual growth rate of 5.4% for the next 7 years.
The U.S. market is estimated at 10.6 billion U.S. dollars, while China is expected to grow at a compound annual growth rate of 8.6%
By 2020, the U.S. blood preparation market is estimated to reach 10.6 billion U.S. dollars. China, the world’s second largest economy, is expected to reach a market size of 12.1 billion U.S. dollars by 2027, with a compound annual growth rate of 8.6%. During the analysis period from 2020 to 2027. Japan and Canada are other notable geographic markets, and between 2020 and 2027, they are each expected to grow by 3% and 4.2%, respectively. In Europe, Germany is expected to grow at a compound annual growth rate of 3.8%.
The compound annual growth rate of blood derivatives is 5.7%
In the global blood derivatives market, the United States, Canada, Japan, China and Europe will drive the market’s 5.3% CAGR growth. The total market size of these regional markets in 2020 is US$6.2 billion, and by the end of the analysis period, it is expected to reach US$8.9 billion. In this regional market cluster, China will remain one of the fastest growing countries. Driven by countries such as Australia, India, and South Korea, the market in the Asia-Pacific region is expected to reach US$7.7 billion by 2027, and the compound annual growth rate in Latin America will reach 6.1% during the entire analysis period.
Choose a competitor (33 features in total):
-
AstraZeneca
-
Baxter International
-
Bristol-Myers Squibb
-
GlaxoSmithKline
-
Leo Pharmaceutical A/S
-
Pfizer
-
Sanofi
-
Xiamen Hisun Chemical Co., Ltd.
Key topics covered:
1. Methodology
two.executive Summary
1. Market overview
-
Influential market insights
-
World market trajectory
-
The impact of Covid-19 and the approaching global recession
2. Focus on selected players
3. Market trends and driving factors
4. Looking to the world
Three, market analysis
-
United States
-
Rest of Europe
-
Australia
-
India
-
Korea
-
Rest of Asia Pacific
-
Argentina
-
Brazil
-
Mexico
-
Rest of Latin America
-
Iran
-
Israel
-
Saudi Arabia
-
United Arab Emirates
-
The rest of the Middle East
-
Africa
IV.competition
-
Total number of companies outlined: 33
For more information about this report, please visit https://www.researchandmarkets.com/r/w49wtd
View the source code version on businesswire.com: https://www.businesswire.com/news/home/20210521005423/zh/
[ad_2]
Source link
